Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan flag Japan · Delayed Price · Currency is JPY
2,217.00
+4.00 (0.18%)
At close: Feb 13, 2026

Zeria Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
97,72499,48893,97898,96085,33196,124
Market Cap Growth
0.27%5.86%-5.03%15.97%-11.23%-0.78%
Enterprise Value
114,629119,281125,376134,397126,409124,464
Last Close Price
2217.002231.242064.912131.851774.451926.45
PE Ratio
13.4510.0112.1615.9721.5430.82
Forward PE
11.0410.1311.3412.5320.6028.59
PS Ratio
1.131.141.241.451.431.73
PB Ratio
1.021.111.181.511.551.71
P/TBV Ratio
1.712.022.584.216.236.90
P/FCF Ratio
-8.6610.129.2010.8215.60
P/OCF Ratio
-7.707.717.529.5313.94
EV/Sales Ratio
1.321.371.661.972.122.25
EV/EBITDA Ratio
6.366.047.308.8610.7415.80
EV/EBIT Ratio
10.949.7813.0314.9119.8636.15
EV/FCF Ratio
-10.3813.5112.4916.0320.20
Debt / Equity Ratio
0.430.460.580.750.950.89
Debt / EBITDA Ratio
2.262.082.693.264.446.34
Debt / FCF Ratio
-3.584.984.606.628.11
Net Debt / Equity Ratio
0.170.200.320.510.740.72
Net Debt / EBITDA Ratio
0.930.891.512.193.445.10
Net Debt / FCF Ratio
-1.532.793.095.146.52
Asset Turnover
0.540.560.530.530.480.49
Inventory Turnover
1.271.511.481.531.511.53
Quick Ratio
0.920.920.760.710.630.43
Current Ratio
1.331.281.061.020.940.69
Return on Equity (ROE)
7.99%11.75%10.58%10.28%7.14%5.75%
Return on Assets (ROA)
4.07%4.92%4.21%4.35%3.23%1.90%
Return on Invested Capital (ROIC)
7.27%9.04%7.61%7.91%4.61%3.14%
Return on Capital Employed (ROCE)
9.70%11.60%10.00%10.30%7.90%5.10%
Earnings Yield
7.43%9.99%8.23%6.26%4.64%3.25%
FCF Yield
-11.55%9.88%10.87%9.24%6.41%
Dividend Yield
2.17%2.11%2.13%1.88%1.97%1.76%
Payout Ratio
-19.89%25.03%25.67%38.83%50.27%
Buyback Yield / Dilution
-0.00%0.21%2.14%2.02%1.38%
Total Shareholder Return
2.18%2.11%2.34%4.01%4.00%3.14%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.